1. Home
  2. LQDT vs WVE Comparison

LQDT vs WVE Comparison

Compare LQDT & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LQDT
  • WVE
  • Stock Information
  • Founded
  • LQDT 1999
  • WVE 2012
  • Country
  • LQDT United States
  • WVE Singapore
  • Employees
  • LQDT N/A
  • WVE N/A
  • Industry
  • LQDT Catalog/Specialty Distribution
  • WVE Biotechnology: Pharmaceutical Preparations
  • Sector
  • LQDT Consumer Discretionary
  • WVE Health Care
  • Exchange
  • LQDT Nasdaq
  • WVE Nasdaq
  • Market Cap
  • LQDT 805.9M
  • WVE 915.6M
  • IPO Year
  • LQDT 2006
  • WVE 2015
  • Fundamental
  • Price
  • LQDT $26.59
  • WVE $9.60
  • Analyst Decision
  • LQDT Strong Buy
  • WVE Strong Buy
  • Analyst Count
  • LQDT 2
  • WVE 16
  • Target Price
  • LQDT $38.50
  • WVE $20.00
  • AVG Volume (30 Days)
  • LQDT 304.4K
  • WVE 1.6M
  • Earning Date
  • LQDT 08-07-2025
  • WVE 07-30-2025
  • Dividend Yield
  • LQDT N/A
  • WVE N/A
  • EPS Growth
  • LQDT 33.77
  • WVE N/A
  • EPS
  • LQDT 0.83
  • WVE N/A
  • Revenue
  • LQDT $465,508,000.00
  • WVE $93,946,000.00
  • Revenue This Year
  • LQDT $31.57
  • WVE N/A
  • Revenue Next Year
  • LQDT $2.58
  • WVE $10.02
  • P/E Ratio
  • LQDT $32.03
  • WVE N/A
  • Revenue Growth
  • LQDT 38.40
  • WVE N/A
  • 52 Week Low
  • LQDT $21.00
  • WVE $5.04
  • 52 Week High
  • LQDT $39.72
  • WVE $16.74
  • Technical
  • Relative Strength Index (RSI)
  • LQDT 59.54
  • WVE 58.88
  • Support Level
  • LQDT $26.09
  • WVE $9.26
  • Resistance Level
  • LQDT $26.82
  • WVE $10.45
  • Average True Range (ATR)
  • LQDT 0.82
  • WVE 0.52
  • MACD
  • LQDT 0.08
  • WVE 0.00
  • Stochastic Oscillator
  • LQDT 68.52
  • WVE 59.34

About LQDT Liquidity Services Inc.

Liquidity Services Inc is an online auction marketplace. It manages and sells inventory and equipment for business and government clients by operating a network of e-commerce marketplaces that enable buyers and sellers to transact in an efficient, automated environment offering across different product categories. The company has four reportable segments: GovDeals, Capital Assets Group (CAG), Retail Supply Chain Group (RSCG), and Machinio. It generates majority of its revenue from Retail Supply Chain Group (RSCG) segment which consists of marketplaces that enable corporations located in the United States and Canada to sell excess, returned, and overstocked consumer goods. Geographically, a substantial portion the company's revenue is generated from its business in United States.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: